•
Dec 31, 2023

Avidity Biosciences Q4 2023 Earnings Report

Total Revenue
$2.19M
Previous year: $2.77M
-20.8%
EPS
-$0.79
Previous year: -$0.88
-10.2%
Gross Profit
$1.58M
Previous year: $2.39M
-33.9%
Cash and Equivalents
$595M
Previous year: $340M
+74.9%
Free Cash Flow
$15.6M
Previous year: -$40M
-139.1%
Total Assets
$629M
Previous year: $639M
-1.6%

Avidity Biosciences

Avidity Biosciences